Show
Sort by
-
- Journal Article
- A1
- open access
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
-
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial
-
- Journal Article
- A1
- open access
High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections
-
- Journal Article
- A1
- open access
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition : an expert opinion